Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligometastatic Cancer”

282 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 282 results

Post-approval studies (Phase 4)Ended earlyNCT04973007
What this trial is testing

Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases

Who this might be right for
Oligometastatic DiseaseLiver MetastasesColorectal Cancer
University of Colorado, Denver 10
Not applicableUnknownNCT02570399
What this trial is testing

High Dose SBRT for Abdominal-Pelvic Lymph Nodal Lesions in Oligometastatic Patients

Who this might be right for
Lymph Node Cancer Metastatic
Istituto Clinico Humanitas 55
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07386704
What this trial is testing

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Peking University First Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05990192
What this trial is testing

SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy

Who this might be right for
Ovarian Cancer Recurrent
Institute of Cancer Research, United Kingdom 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06851819
What this trial is testing

Tislelizumab in Combination with Chemotherapy ± Radiotherapy for Extensive-Stage Oligometastatic Small Cell Lung Cancer.

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Hebei Medical University Fourth Hospital 64
Not applicableEnded earlyNCT02542202
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

Who this might be right for
Metastatic Renal Cell CancerRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
University of Chicago 25
Early research (Phase 1)Active Not RecruitingNCT05079698
What this trial is testing

Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT04190446
What this trial is testing

Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaOligometastatic Prostate CarcinomaProstate Adenocarcinoma+2 more
Mayo Clinic 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT01446744
What this trial is testing

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET)

Who this might be right for
Metastatic Tumors
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 99
Testing effectiveness (Phase 2)Looking for participantsNCT03548428
What this trial is testing

Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)

Who this might be right for
SarcomaRadiosurgery
Centre Antoine Lacassagne 103
Early research (Phase 1)WithdrawnNCT03477864
What this trial is testing

Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer

Who this might be right for
Stage III Prostate CancerStage IIIA Prostate CancerStage IIIB Prostate Cancer+4 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Testing effectiveness (Phase 2)Active Not RecruitingNCT03599765
What this trial is testing

Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor

Who this might be right for
Oligometastatic Malignant Solid Neoplasm
M.D. Anderson Cancer Center 380
Large-scale testing (Phase 3)Looking for participantsNCT06467097
What this trial is testing

Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma

Who this might be right for
Kidney Neoplasm
Samsung Medical Center 88
Testing effectiveness (Phase 2)Study completedNCT02855203
What this trial is testing

Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours

Who this might be right for
Renal Cell Carcinoma
Peter MacCallum Cancer Centre, Australia 30
Not applicableActive Not RecruitingNCT05951127
What this trial is testing

Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaOligometastatic Disease
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 141
Testing effectiveness (Phase 2)Active Not RecruitingNCT04619069
What this trial is testing

Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05053152
What this trial is testing

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Who this might be right for
Oligometastatic Prostate CarcinomaProstate AdenocarcinomaProstate Ductal Adenocarcinoma+2 more
NRG Oncology 194
Large-scale testing (Phase 3)Active Not RecruitingNCT05721755
What this trial is testing

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+8 more
ECOG-ACRIN Cancer Research Group
Testing effectiveness (Phase 2)Looking for participantsNCT07053085
What this trial is testing

Surgery and Radiotherapy in People With Breast Cancer

Who this might be right for
Metastatic Breast CancerHER2-positive Breast Cancer
Memorial Sloan Kettering Cancer Center 162
Testing effectiveness (Phase 2)Looking for participantsNCT05982678
What this trial is testing

Basket Study for Oligo-metastatic Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
The Netherlands Cancer Institute 72
Load More Results
290